WNT signalling in prostate cancer
- PMID: 28895566
- DOI: 10.1038/nrurol.2017.144
WNT signalling in prostate cancer
Abstract
Genome sequencing and gene expression analyses of prostate tumours have highlighted the potential importance of genetic and epigenetic changes observed in WNT signalling pathway components in prostate tumours - particularly in the development of castration-resistant prostate cancer. WNT signalling is also important in the prostate tumour microenvironment, in which WNT proteins secreted by the tumour stroma promote resistance to therapy, and in prostate cancer stem or progenitor cells, in which WNT-β-catenin signals promote self-renewal or expansion. Preclinical studies have demonstrated the potential of inhibitors that target WNT receptor complexes at the cell membrane or that block the interaction of β-catenin with lymphoid enhancer-binding factor 1 and the androgen receptor, in preventing prostate cancer progression. Some WNT signalling inhibitors are in phase I trials, but they have yet to be tested in patients with prostate cancer.
Similar articles
-
Wnt/Beta-Catenin Signaling and Prostate Cancer Therapy Resistance.Adv Exp Med Biol. 2019;1210:351-378. doi: 10.1007/978-3-030-32656-2_16. Adv Exp Med Biol. 2019. PMID: 31900917 Review.
-
Wnt/β-catenin signalling in prostate cancer.Nat Rev Urol. 2012 Aug;9(8):418-28. doi: 10.1038/nrurol.2012.116. Epub 2012 Jun 19. Nat Rev Urol. 2012. PMID: 22710668 Review.
-
Revisiting the role of Wnt/β-catenin signaling in prostate cancer.Mol Cell Endocrinol. 2018 Feb 15;462(Pt A):3-8. doi: 10.1016/j.mce.2017.02.008. Epub 2017 Feb 9. Mol Cell Endocrinol. 2018. PMID: 28189566 Free PMC article. Review.
-
MiR-182 promotes prostate cancer progression through activating Wnt/β-catenin signal pathway.Biomed Pharmacother. 2018 Mar;99:334-339. doi: 10.1016/j.biopha.2018.01.082. Biomed Pharmacother. 2018. PMID: 29353209
-
Epigenetic demethylation of sFRPs, with emphasis on sFRP4 activation, leading to Wnt signalling suppression and histone modifications in breast, prostate, and ovary cancer stem cells.Int J Biochem Cell Biol. 2019 Apr;109:23-32. doi: 10.1016/j.biocel.2019.01.016. Epub 2019 Jan 30. Int J Biochem Cell Biol. 2019. PMID: 30710752
Cited by
-
miR-425-5p suppresses tumorigenesis and DDP resistance in human-prostate cancer by targeting GSK3β and inactivating the Wnt/β-catenin signaling pathway.J Biosci. 2019 Sep;44(4):102. J Biosci. 2019. PMID: 31502580
-
The miR-96 and RARγ signaling axis governs androgen signaling and prostate cancer progression.Oncogene. 2019 Jan;38(3):421-444. doi: 10.1038/s41388-018-0450-6. Epub 2018 Aug 17. Oncogene. 2019. PMID: 30120411 Free PMC article.
-
Kinesin family member 3A induces related diseases via wingless-related integration site/β-catenin signaling pathway.Sci Prog. 2023 Jan-Mar;106(1):368504221148340. doi: 10.1177/00368504221148340. Sci Prog. 2023. PMID: 36594221 Free PMC article. Review.
-
Mechanisms of Resistance to Second-Generation Antiandrogen Therapy for Prostate Cancer: Actual Knowledge and Perspectives.Med Sci (Basel). 2022 Apr 28;10(2):25. doi: 10.3390/medsci10020025. Med Sci (Basel). 2022. PMID: 35645241 Free PMC article. Review.
-
Concise Review: Prostate Cancer Stem Cells: Current Understanding.Stem Cells. 2018 Oct;36(10):1457-1474. doi: 10.1002/stem.2859. Epub 2018 Aug 27. Stem Cells. 2018. PMID: 29845679 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical